Elevance Health Inc. beat EPS estimates 89% of the time across 18 reported quarters (16 beats, 2 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $6.15 | — | — | Miss |
| Q1 FY2026 | $10.35 | — | — | Miss |
| Q1 FY2026 | $11.03 | $12.58 | +14.1% | Beat |
| 2026-01-28 | $3.10 | $3.33 | +7.4% | Beat |
| Q3 FY2025 | $4.93 | $6.03 | +22.3% | Beat |
| Q3 FY2025 | $8.91 | $8.84 | -0.8% | Miss |
| Q3 FY2025 | $11.41 | $11.97 | +4.9% | Beat |
| 2025-01-23 | $3.80 | $3.84 | +1.1% | Beat |
| Q3 FY2024 | $9.66 | $8.37 | -13.3% | Miss |
| Q3 FY2024 | $10.01 | $10.12 | +1.1% | Beat |
| Q3 FY2024 | $10.53 | $10.64 | +1.0% | Beat |
| 2024-01-24 | $5.55 | $5.62 | +1.3% | Beat |
Back to ELV overview · ELV holders · ELV KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.